October 11, 2016
(from left) Mr Israeli, Mr Matsumori, Mr Iwasaki at Tokyo Press Conference A Japan-based joint venture between Takeda Pharmaceutical and Teva Holdings aims to become a number one player in what it describes as the “off-patent drug” market, which combines...read more